Document vB9kp7Z9w386kMBdK9XZ0pK69

Document 1 Ref. Ares(2019)792881 - 11/02/2019 From: Sent: To: Cc: Subject: (SANTE) jeudi 17 janvier 2019 18:14 (SANTE) (SANTE) RE: Meeting request on EFSA's scientific opinion on PFOS and PFOA Dear , The conclusions of the EFSA opinion on the risk to human health related to the presence of peruorooctane sulfonic acid (PFOS) and peruorooctanoic acid (PFOA) in food will be reviewed in parallel with the finalisation of the EFSA scientific opinion on the risks to human health, related to the presence in food of perfluoroalkylated substances other than PFOS and PFOA. As no discussions on possible regulatory actions are planned prior to the finalisation of this second opinion and a possible review of the opinion on PFOS and PFOA, a meeting with DG SANTE would not be useful at this stage. In your e-mail you mention new scientific developments and evidence. Could you please provide us with a list of the studies you refer to, so that EFSA can verify whether they contain new information, in addition to the studies already considered by EFSA. Kind regards From: Sent: Wednesday, January 16, 2019 4:34 PM To: (SANTE); (SANTE) Subject: Meeting request on EFSA's scientific opinion on PFOS and PFOA Dear , Dear , I am writing to you on behalf of 3M regarding the recent European Food Safety Authority (EFSA) scientific opinion on the risk to human health related to the presence of perfluorooctane sulfonic acid (PFOS) and perfluorooctanoic acid (PFOA) in food. 3M very much appreciates and supports EFSA's mandate and all the work the Authority is doing to protect European citizens from food-related health risks. Following the adoption of the EFSA opinion on PFOS and PFOA in December 2018, we would very much appreciate the opportunity to meet with the European Commission to discuss next steps from a regulatory point of view, as well as how these might take into account some of the latest scientific developments related to effects on cholesterol levels - which are not reflected as far as we are aware in the EFSA opinion. As you might know, 3M completed a voluntary phase out of manufacture and use of PFOS and PFOA in 2008. We nevertheless remained committed to furthering scientific research of PFOS and PFOA and to working with regulators, scientists and community stakeholders. In addition to fundingstudiesatleadingglobalresearchinstitutions,3Mhas.over thepastthreedecades. conducted,collaboratedonandpublishedhundredsofits ownstudies on PFAS. Ourtoxicologist,INI.andourepidemiologist,INN.wouldbe happy to jointhemeetingto provideanoverviewofthelatestscientificevidence. Akrmessbote `Would youbeavailabletomeetinFebruaryorearlyMarch? -- 3M AppltoiLiefed." a Pe I |wv aMcom